Virtu Financial LLC Cybin Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.38 - $0.65 $15,182 - $25,970	39,955 Added 29.47%	175,547 $72,000
Q3 2023 Nov 14, 2023	BUY	$0.29 - $0.63 $39,321 - $85,422	135,592 New	135,592 $72,000
Q1 2023 May 01, 2023	BUY	$0.3 - $0.56 $16,104 - $30,061	53,681 Added 59.34%	144,148 $55,000
Q4 2022 Feb 15, 2023	BUY	$0.26 - $0.47 $11,993 - $21,680	46,129 Added 104.04%	90,467 $27,000
Q3 2022 Nov 07, 2022	BUY	$0.54 - $1.11 $23,942 - $49,215	44,338 New	44,338 $21,000

Q1 2022 May 17, 2022	SELL	$0.74 - $1.22 $78,104 - $128,767	-105,547 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.13 - $2.31 $39,592 - $80,937	35,038 Added 49.69%	105,547 $127,000
Q3 2021 Nov 12, 2021	BUY	$1.83 - $3.18 $129,031 - $224,218	70,509 New	70,509 $154,000

109

243M

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $43.2M
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.